Catalyst Wire Dossier Catalyst Wire Dossier

Zinbryta

daclizumab high yield process · Biogen
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Zinbryta, covering 2016-07-11 to 2018-06-28. Get the full timeline:

Most recent: EMA Withdrawn: Zinbryta (daclizumab) — Biogen Idec Ltd

See pricing